Pharmaceuticals and Healthcare Reports 5EU Dyslipidemia Market Size, Share, Growth, Trend Zum Anzeigen klicken
  • Kommentare

Pharmaceuticals and Healthcare Reports

5EU Dyslipidemia Market Size, Share, Growth, Trend

Veröffentlicht am in "Gesundheit & Fitness, Gesundheit & Fitness", Sprache — English. 3 Seiten.
The launch of the proprotein convertase subtilisin/kexin type 9 (PCSK9) biologics and the cholesteryl ester transfer protein (CETP) inhibitors will reshape the sales landscape of the dyslipidemia market moving forward. Mehr anzeigen
KOSTENLOSES Abonnement

Andere Publikationen von "Pharmaceuticals and Healthcare Reports"

Alle Publikationen anzeigen